Open AccessBiomarker Use for Dementia With Lewy Body Diagnosis
Author(s) -
Melissa J. Armstrong,
David J. Irwin,
James B. Leverenz,
Noheli Gamez,
Angela Taylor,
James E. Galvin
Publication year - 2020
Publication title -
alzheimer disease and associated disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 95
eISSN - 1546-4156
pISSN - 0893-0341
DOI - 10.1097/wad.0000000000000414
Subject(s) - positron emission tomography , medicine , dementia with lewy bodies , dementia , quantitative electroencephalography , magnetic resonance imaging , single photon emission computed tomography , neuropsychology , context (archaeology) , emission computed tomography , lewy body , biomarker , radiology , neuroimaging , polysomnography , pathology , electroencephalography , psychiatry , cognition , disease , paleontology , biochemistry , chemistry , biology
Dementia with Lewy body (DLB) diagnostic criteria define "indicative" and "supportive" biomarkers, but clinical practice patterns are unknown.